ERIN FRANK: Open Payments
NPI 1467424226 · OLEAN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$419 in 19 payments from 10 companies in 2025. Trend: 2023 $1,662 · 2024 $843 · 2025 $419
Food & beverage: $419
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $151 |
| ABBVIE INC. | 3 | $73 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Astellas Pharma US Inc | 1 | $34 |
| Boston Scientific Corporation | 1 | $26 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
Products named: Ozempic, UBRELVY, Veozah, WATCHMAN FLX, VOQUEZNA, NURTEC ODT, VRAYLAR, GIVLAARI.
Industry payments across NY — which companies pay providers there.
